Mirae Asset Global Investments Co., Ltd. Humacyte, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Humacyte, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 5,992 shares of HUMA stock, worth $10,785. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,992
Previous 4,136
44.87%
Holding current value
$10,785
Previous $7,000
71.43%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding HUMA
# of Institutions
171Shares Held
54.5MCall Options Held
1.1MPut Options Held
808K-
Black Rock Inc. New York, NY7.14MShares$12.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$12.6 Million0.0% of portfolio
-
State Street Corp Boston, MA4.39MShares$7.9 Million0.0% of portfolio
-
Center Book Partners LP Greenwich, CT3.43MShares$6.17 Million0.42% of portfolio
-
Geode Capital Management, LLC Boston, MA2.95MShares$5.31 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $185M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...